All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-24788140

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	24788140	A799G	RT	P	Carcinoma, Hepatocellular	G R S C L	View
2	24788140	A987G	RT	P	Carcinoma, Hepatocellular	G R S C L	View
3	24788140	T1055A	RT	P	Carcinoma, Hepatocellular	G R S C L	View
4	24788140	I224V	RT	P	Carcinoma, Hepatocellular	G R S C L	View
5	24788140	M309K	RT	P	Carcinoma, Hepatocellular	G R S C L	View
6	24788140	A942S	RT	P	Carcinoma, Hepatocellular	G R S C L	View
7	24788140	C936T	RT	P	Carcinoma, Hepatocellular	G R S C L	View
8	24788140	T1069A	RT	P	Carcinoma, Hepatocellular	G R S C L	View
9	24788140	T1071C	RT	P	Carcinoma, Hepatocellular	G R S C L	View
10	24788140	T843C	RT	P	Carcinoma, Hepatocellular	G R S C L	View
11	24788140	T870C	RT	P	Carcinoma, Hepatocellular	G R S C L	View
12	24788140	T895A	RT	P	Carcinoma, Hepatocellular	G R S C L	View
13	24788140	T906R	RT	P	Carcinoma, Hepatocellular	G R S C L	View
14	24788140	C256S	RT	P	Carcinoma, Hepatocellular	G R S C L	View
15	24788140	C294T	RT	P	Carcinoma, Hepatocellular	G R S C L	View
16	24788140	C300G	RT	P	Carcinoma, Hepatocellular	G R S C L	View
17	24788140	C314S	RT	P	Carcinoma, Hepatocellular	G R S C L	View
18	24788140	C620S	RT	P	Carcinoma, Hepatocellular	G R S C L	View
19	24788140	C660S	RT	P	Carcinoma, Hepatocellular	G R S C L	View
20	24788140	F134S	S	S	Carcinoma, Hepatocellular	G R S I C L	View
21	24788140	H271Q	RT	P	Carcinoma, Hepatocellular	G R S C L	View
22	24788140	H617Q	RT	P	Carcinoma, Hepatocellular	G R S C L	View
23	24788140	I570V	RT	P	Carcinoma, Hepatocellular	G R S C L	View
24	24788140	M655K	RT	P	Carcinoma, Hepatocellular	G R S C L	View
25	24788140	P49R	S	S	Carcinoma, Hepatocellular	G R S I C L	View
26	24788140	S204R	S	S	Carcinoma, Hepatocellular	G R S I C L	View
27	24788140	S213T	RT	P	Carcinoma, Hepatocellular	G R S C L	View
28	24788140	S559T	RT	P	Carcinoma, Hepatocellular	G R S C L	View
29	24788140	T48M	S	S	Carcinoma, Hepatocellular	G R S I C L	View
30	24788140	T555C	RT	P	Carcinoma, Hepatocellular	G R S C L	View
31	24788140	T766A	RT	P	Carcinoma, Hepatocellular	G R S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.